Needham Cuts Equifax (EFX) Price Target to $190

Needham reiterates its Buy rating on Equifax with a price target of $190, a 18.45% upside from the current price.

By EarningsIQ Research Desk · Published Oct 16, 2026, 2:22 PM EDT

Reviewed by automated data checks against the source data. How we make and check alerts

Needham cut its price target on Equifax Inc. ($EFX) to $190 from $245 on October 13, 2026, and rates the stock "Buy".

Since the rating, $EFX is up 8.2% to date (from the $149.08 close on Oct 13, 2026).

EFX Equifax Inc.

$161.25 -23.98% year to date

Daily close · Oct 16, 2026

Key Points

On October 13, 2026, Needham reiterated its Buy rating on Equifax Inc. with a price target of $190, down from $245.
Needham's $190 price target implies 18.45% upside from Equifax Inc.'s ($EFX) current $160.40 share price.
Equifax's stock recently traded around $160.4, which is about 15.6% below the new target price.
The company is set to report earnings on October 20, 2026, following a year-over-year revenue growth of 10.6%.

Get $EFX trade alerts by text

We text you when insiders, Congress or big funds trade $EFX. Free.

Not investment advice. EarningsIQ is not a registered investment adviser, and this automated Equifax Inc. alert may contain errors. Disclosures

Needham has reaffirmed its Buy rating on Equifax Inc. (NYSE: EFX) on October 13, 2026, setting a price target of $190. This target is a reduction from the prior target of $245. As of October 16, 2026, the stock was recently trading at $160.4, which is about 15.6% below the analyst's new price target.

Other Institutional Activity in Equifax

Several other institutional investors have been adjusting their positions in Equifax. Blackrock Inc. trimmed its holdings by 66,237 shares, ending with 9,396,150 shares valued at approximately $1.52 billion. Vanguard Capital Management LLC also reduced its stake by 44,603 shares, bringing its total to 7,780,433 shares worth about $1.25 billion. Meanwhile, Harris Associates L.P. cut its position by 82,070 shares, holding 7,447,263 shares valued at around $1.20 billion.

Equifax Inc. Stock Up 1.0%

Equifax's stock is currently trading around $160.4, which is significantly below the new price target set by Needham. The stock's positioning suggests a potential opportunity for investors if the company can meet its growth expectations, especially given its recent revenue growth of 10.6% year-over-year.

12-month forecast

$EFX price target

Equifax Inc. daily closes and this analyst's $190 target. Not advice.

Recent Earnings

Equifax reported trailing twelve-month revenue of approximately $6.44 billion and an earnings per share (EPS) of $5.69. The company has a net margin of 10.7% and a return on equity (ROE) of 14.3%. The next earnings report is scheduled for October 20, 2026, which could provide further insights into the company’s performance.

Earnings drift grade

Outlook vs expectations on the last report — not price action.

D- 34/100

Reported Apr 21, 2026

Forward outlook
3 target cuts vs 0 raises.
EPS & revenue
EPS beat estimates by 8.3%. Revenue beat estimates by 1.0%.
Profit surprise
EBITDA met by 2 percent. Operating income met by 1 percent.
Pre-earnings setup
Expectations were about average.
Analyst signal
3 target cuts.
Earnings quality
Gross margin down 1.0 points. Operating margin up 1.1 points. Positive free cash flow.

Earnings Call Summary

Equifax had a strong first quarter with revenue of $1.649 billion up 14 percent and earnings per share of $1.86 up 22 percent, both ahead of expectations. The big driver was U.S. mortgage revenue which jumped 38 percent, boosted by new Work Number Indicator products and strong mortgage activity in February before interest rates rose. Management is excited about their artificial intelligence driven products and record numbers of pending patents, but they are holding full year guidance steady due to concerns about the Iran conflict and rising interest rates dampening mortgage demand over the rest of the year.

Guidance Equifax reaffirmed its full year 2026 guidance of about $6.745 billion in revenue and $8.54 in earnings per share despite strong first quarter results. Management kept guidance steady because of economic uncertainty tied to the Iran conflict and interest rate volatility, which pressured mortgage volumes in March and April. They still expect mortgage revenue to grow over 20 percent for the full year and diversified markets to grow in the high single digits.

Very weak report. The release materially worsened the forward outlook.

Insider Buying and Selling at Equifax Inc.

Insider trading activity at Equifax shows several sales. On May 1, 2026, Chief Operating Officer John W. Gamble Jr. sold 3,500 shares at an average price of $176.54, totaling about $617,890. On May 7, 2026, Officer Chad M. Borton sold 2,455 shares for about $426,900 at an average price of $173.89. Additionally, on September 3, 2026, Gamble sold another 4,500 shares at an average price of $187.96, valued at approximately $845,820.

Analysts Set New Price Targets

On the same day as Needham's announcement, Morgan Stanley maintained an Overweight rating on Equifax, adjusting its target from $225 to $205. Other analysts have also been active; Wells Fargo kept its Overweight rating but lowered its target from $212 to $200, while BMO Capital reduced its target from $179 to $160, maintaining a Market Perform rating.

About Equifax

Equifax Inc. is a technology company based in Atlanta, Georgia, that focuses on data analytics. It operates through three segments: Workforce Solutions, U.S. Information Solutions, and International. The company plays a key role in providing data and insights that help businesses make informed decisions.

Bottom Line

Investors will be watching Equifax closely as it prepares to report earnings on October 20, 2026. With Needham's recent rating reaffirmation and a reduced price target, the market will be looking for signs of growth in the company's upcoming performance.